Role of invasive electrophysiologic testing in risk stratification for sudden cardiac death

Journal of Invasive Cardiology

Volumn 13, Issue 11, 2001, Pages 758-762

  Saeed, Mohammad ^a   Homoud, Munther K ^a   Wang, Paul J ^a   Estes III, N A Mark ^a   Link, Mark S ^a  

^a TUFTS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONGESTIVE CARDIOMYOPATHY; CORONARY ARTERY ATHEROSCLEROSIS; HEART FUNCTION TEST; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; RECURRENT DISEASE; REVIEW; RISK FACTOR; SUDDEN DEATH;

CARDIOMYOPATHY, DILATED; CARDIOMYOPATHY, HYPERTROPHIC; CORONARY ARTERIOSCLEROSIS; DEATH, SUDDEN, CARDIAC; ELECTROPHYSIOLOGIC TECHNIQUES, CARDIAC; HUMANS; RECURRENCE; RISK FACTORS;

EID: 0035512167     PISSN: 10423931     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Brugada P, Green M, Abdollah H, Wellens HJJ. Significance of ventricular arrhythmias initiated by programmed ventricular stimulation: The importance of the type of ventricular arrhythmia induced and the number of premature stimuli required. Circulation 1984;6:87-92.
2. Bigger JT, Reiffel JA, Livelli FD, Wang PJ. Sensitivity, specificity, and reproducibility of programmed ventricular stimulation. Circulation 1986;73(Suppl II):II73-II78.
3. Richards D, Byth K, Ross D, Uther J. What is the best predictor of spontaneous ventricular tachycardia and sudden death after myocardial infarction? Circulation 1991;83:756-763.
4. Marchlinski F, Buxton A, Waxman H, Josephson M. Identifying patients at risk of sudden death after myocardial infarction: Value of the response to programmed stimulation, degree of ventricular ectopic activity and severity of left ventricular dysfunction. Am J Cardiol 1983;52:1190-1196.
5. Zehender M, Brugada P, Geibel A, et al. Programmed electrical stimulation in healed myocardial infarction using a standardized ventricular stimulation protocol. Am J Cardiol 1987;59:578-585.
6. Moss AJ, Hall J, Cannom DS, et al. Improved survival with an implantable defibrillator in patients with coronary disease at high risk for ventricular arrhythmias. N Engl J Med 1996;335:1993-1940.
7. Daubert J, Higgins S, Zareba W, Wilber D. Comparative survival of MADIT-eligible but noninducible patients. J Am Coll Cardiol 1997;29:78A.
8. Buxton AE, Lee KL, Fisher JD, et al. A randomized study of the prevention of sudden death in patients with coronary artery disease. N Engl J Med 1999;341:1882-1890.
9. Buxton A, Lee K, DiCarlo L, et al. Electrophysiologic testing to identify patients with coronary artery disease who are at risk for sudden death. Multicenter Unsustained Tachycardia Trial Investigators. N Engl J Med 2000;342:1937-1945.
10. Milner PG, DiMarco JP, Lerman BB. Electrophysiological evaluation of sustained ventricular tachyarrhythmias in idiopathic dilated cardiomyopathy. Pacing Clin Electrophysiol 1988;11:562-568.
11. Liem LB, Swerdlow CD. Value of electropharmacologic testing in idiopathic dilated cardiomyopathy and sustained ventricular tachyarrhythmias. Am J Cardiol 1988;62:611-616.
12. Poll D, Marchlinski F, Buxton A, Josephson M. Usefulness of programmed stimulation in idiopathic dilated cardiomyopathy. Am J Cardiol 1986;58:992-997.
13. Das SK, Morady F, DiCarlo L, et al. Prognostic usefulness of programmed ventricular stimulation in idiopathic dilated cardiomyopathy without symptomatic ventricular arrhythmias. Am J Cardiol 1986;58:998-1000.
14. Turitto G, Ahuja RK, Caref EB, El-Sherif N. Risk stratification for arrhythmic events in patients with nonischemic dilated cardiomyopathy and nonsustained ventricular tachycardia: Role of programmed ventricular stimulation and the signal-averaged electrocardiogram. J Am Coll Cardiol 1994;24:1523-1528.
15. Cohn JN, Johnson GR, Shabetai R, et al. Ejection fraction, peak exercise oxygen consumption, cardiothoracic ratio, ventricular arrhythmias, and plasma norepinephrine as determinants of prognosis in heart failure. The V-HeFT VA Cooperative Studies Group. Circulation 1993;87:V15-V16.
16. Caceres J, Jazayeri M, McKinnie J, et al. Sustained bundle branch reentry as a mechanism of clinical tachycardia. Circulation 1989;79:256-270.
17. Cohen T, Chien W, Lurie K, et al. Radiofrequency catheter ablation for treatment of bundle branch reentrant ventricular tachycardia: Results and long-term follow-up. J Am Coll Cardiol 1991;18:1767-1773.
18. Tchou P, Jazayeri M, Denker S, et al. Transcatheter electrical ablation of right bundle branch. A method of treating macroreentrant ventricular tachycardia attributed to bundle branch reentry. Circulation 1988;72:246-257.
19. Fananapazir L, Chang AC, Epstein SE, McAreavey D. Prognostic determinants in hypertrophic cardiomyopathy. Circulation 1992;86:730-740.
20. Kuck K, Kunze K, Schluter M, et al. Programmed electrical stimulation in hypertrophic cardiomyopathy. Results in patients with and without cardiac arrest or syncope. Eur Heart J 1988;9:177-185.
21. Maron B, Shen W, Link M, et al. Efficacy of implantable cardioverter defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy. N Engl J Med 2000;342:365-373.
22. Poole JE, Mathisen TL, Kudenchuk PJ, et al. Long-term outcome in patients who survive out of hospital ventricular fibrillation and undergo electrophysiologic studies: Evaluation by electrophysiologic subgroups. J Am Coll Cardiol 1990;16:657-665.
23. Wilber D, Garan H, Finkelstein D, et al. Out-of-hospital cardiac arrest. Use of electrophysiologic testing in the prediction of long-term outcome. N Engl J Med 1988;318:19-24.
24. Mittal S, Iwai S, Stein KM, et al. Long-term outcome of patients with unexplained syncope treated with an electrophysiologic-guided approach in the implantable cardioverter-defibrillator era. J Am Coll Cardiol 1999;34:1082-1089.
25. Link M, Kim K, Homoud M, et al. Long-term outcome of patients with syncope associated with coronary artery disease and a nondiagnostic electrophysiologic evaluation. Am J Cardiol 1999;83:1334-1337.
26. Krahn AD, Klein GJ, Norris C, Yee R. The etiology of syncope in patients with negative tilt table and electrophysiological testing. Circulation 1995;92:1819-1824.
27. Bass EB, Elson JJ, Fogoros RN, et al. Long-term prognosis of patients undergoing electrophysiologic studies for syncope of unknown origin. Am J Cardiol 1988;62:1186-1191.
28. Link MS, Costeas XF, Griffith JL, et al. High incidence of appropriate implantable cardioverter-defibrillator therapy in patients with syncope of unknown etiology and inducible ventricular arrhythmias. J Am Coll Cardiol 1997;29:370-375.
29. Knight BP, Goyal R, Pelosi F, et al. Outcome of patients with non-ischemic dilated cardiomyopathy and unexplained syncope treated with an implantable defibrillator. J Am Coll Cardiol 1999;33:1964-1970.
30. Saeed M, Saba S, Wang P, et al. High risk of ventricular arrhythmias in long-term follow-up of patients with idiopathic dilated cardiomyopathy and unexplained syncope. Circulation 2000;102:SII-S370.
31. Link M, Costeas X, Homoud M, et al. Significance of inducible ventricular fibrillation: Data from implantable cardioverter defibrillators. Pacing Clin Electrophysiol 1997;20.
32. Link M, Gupta N, Homoud M. Inducible ventricular fibrillation is a predictor of recurrent arrhythmias in patients presenting with syncope or cardiac arrest. J Am Coll Cardiol 1999;33:118A.